计算生物学
生物标志物
核酸
纳米技术
生物标志物发现
癌症生物标志物
癌症
计算机科学
生物
材料科学
蛋白质组学
生物化学
遗传学
基因
作者
Lingying Xia,Yanan Tang,Jie Zhang,Tianyu Dong,Rongxing Zhou
标识
DOI:10.1016/j.semcancer.2021.12.012
摘要
The most commonly used clinical methods are enzyme-linked immunosorbent assay (ELISA) and quantitative PCR (qPCR) in which ELISA was applied for the detection of protein biomarkers and qPCR was especially applied for nucleic acid biomarker analysis. Although these constructed methods have been applied in wide range, they also showed some inherent shortcomings such as low sensitivity, large sample volume and complex operations. At present, many methods have been successfully constructed on the basis of DNA nanotechnology with the merits of high accuracy, rapid and simple operation for cancer biomarkers assay. In this review, we summarized the bioassay strategies based on DNA nanotechnology from the perspective of the analytical attributes for the first time and discussed and the feasibility of the reported strategies for clinical application in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI